Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Diffuse Intrinsic Pontine Glioma × Cilengitide × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 5 Oligodendroglioma 3 Lymphoma, Follicular 3 Gliosarcoma 3 Brain Neoplasms 3 Astrocytoma 3 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Optic Nerve Glioma 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Renal Insufficiency 1 Recurrence 1 Primary Myelofibrosis 1 Precancerous Conditions 1

Interventions

Radiotherapy 5 Temozolomide 4 Radiation 3 Irinotecan 3 Bevacizumab 3 ribociclib 2 abemaciclib 2 Vorinostat 2 Mebendazole 2 Everolimus 2 Dasatinib 2 vandetanib 1 temsirolimus 1 sargramostim 1 reolysin 1 pembrolizumab 1 ovex 1 nimotuzumab 1 irinotecan sucrosofate 1 dinutuximab 1 crenolanib 1 adavosertib 1 Vincristine 1 Valproic Acid 1 Sirolimus 1 Re-Irradiation 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Piperazine 1 Pharmacogenomic Variants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01165333 2026-03-16

CILENT

Centre Oscar Lambret

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡